7
Participants
Start Date
January 24, 2014
Primary Completion Date
April 10, 2018
Study Completion Date
May 29, 2019
EZN-2279
Weekly administration of EZN-2279 via IM injection
Adagen
Albert Einstein College of Medicine, The Bronx
UBMD, Buffalo
Penn State College of Medicine The Milton S. Hershey Medical Center, Hershey
Children's Hospital Los Angeles, Los Angeles
University of California San Francisco, San Francisco
National Jewish Health, Denver
Lead Sponsor
Leadiant Biosciences, Inc.
INDUSTRY